Literature DB >> 9383634

Lipopolysaccharides and beta-glucuronidase activity in choledochal bile in relation to choledocholithiasis.

T Osnes1, O Sandstad, V Skar, M Osnes.   

Abstract

Common duct gallstones are mainly of the brown pigment type, which are usually attributed to bacterial factors. Bacterial beta-glucuronidase most probably plays a role in the pathogenesis in many but not all patients. The role of other bacterial factors is more undecided. The aims of this study were to investigate a possible association between lipopolysaccharides (LPS) and choledocholithiasis, and to examine the interrelationship to beta-glucuronidase. Common duct bile obtained at endoscopic retrograde cholangiography in 86 patients was assayed for LPS by a limulus amebocyte lysate test, and beta-glucuronidase activity at pH 7.0 was measured. We found that both elevated concentration of LPS and the presence of juxtapapillary duodenal diverticula were associated with common duct stones (p < 0.01, both). Patients who had their common duct stones removed recently had a lower LPS concentration and a lower activity of beta-glucuronidase than those who had a stone in situ (p < 0.01, both), but still higher LPS concentration than those without choledocholithiasis at all (p < 0.01). In multiple logistic regression analysis, elevated LPS was the significant predictor of common duct stones (p < 0.01), and not confounding with neither beta-glucuronidase nor juxtapapillary diverticula. We conclude that gram-negative bacteria convey bacterial factors associated with choledocholithiasis, by mechanisms independent of, and additional to beta-glucuronidase.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9383634     DOI: 10.1159/000201480

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  14 in total

1.  ATP-binding cassette sterol transporters are differentially expressed in normal and diseased human gallbladder.

Authors:  Jai Hoon Yoon; Ho Soon Choi; Dae Won Jun; Kyo-Sang Yoo; Jin Lee; Sun Young Yang; Rahul Kuver
Journal:  Dig Dis Sci       Date:  2012-11-22       Impact factor: 3.199

Review 2.  Advances in cholangiocyte immunobiology.

Authors:  Gaurav Syal; Michel Fausther; Jonathan A Dranoff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-06       Impact factor: 4.052

3.  Primary sclerosing cholangitis: A review and update.

Authors:  James H Tabibian; Christopher L Bowlus
Journal:  Liver Res       Date:  2017-12

4.  Pigment gallstone pathogenesis: slime production by biliary bacteria is more important than beta-glucuronidase production.

Authors:  L Stewart; R Ponce; A L Oesterle; J M Griffiss; L W Way
Journal:  J Gastrointest Surg       Date:  2000 Sep-Oct       Impact factor: 3.452

5.  Interferon gamma accelerates NF-kappaB activation of biliary epithelial cells induced by Toll-like receptor and ligand interaction.

Authors:  K Harada; K Isse; Y Nakanuma
Journal:  J Clin Pathol       Date:  2006-02       Impact factor: 3.411

Review 6.  Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies.

Authors:  James H Tabibian; Steven P O'Hara; Keith D Lindor
Journal:  Scand J Gastroenterol       Date:  2014-07-03       Impact factor: 2.423

7.  Prospective Clinical Trial of Rifaximin Therapy for Patients With Primary Sclerosing Cholangitis.

Authors:  James H Tabibian; Andrea Gossard; Mounif El-Youssef; John E Eaton; Jan Petz; Roberta Jorgensen; Felicity B Enders; Anilga Tabibian; Keith D Lindor
Journal:  Am J Ther       Date:  2017 Jan/Feb       Impact factor: 2.688

8.  Gallstones containing bacteria are biofilms: bacterial slime production and ability to form pigment solids determines infection severity and bacteremia.

Authors:  Lygia Stewart; J McLeod Griffiss; Gary A Jarvis; Lawrence W Way
Journal:  J Gastrointest Surg       Date:  2007-08       Impact factor: 3.452

Review 9.  Biliary innate immunity: function and modulation.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Mediators Inflamm       Date:  2010-07-27       Impact factor: 4.711

10.  Cholangiopathy with respect to biliary innate immunity.

Authors:  Kenichi Harada; Yasuni Nakanuma
Journal:  Int J Hepatol       Date:  2011-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.